VICENTE
ALBEROLA CANDEL
EMÉRITO/A UNIVERSIDAD
Institute Catalá Oncología
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institute Catalá Oncología (5)
2011
-
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine
Lung Cancer, Vol. 71, Núm. 2, pp. 191-198
2010
-
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients
Lung Cancer, Vol. 68, Núm. 3, pp. 491-497
2006
-
Polymorphisms in DNA repair genes modulate survival in cisplatin/ gemcitabine-treated non-small-cell lung cancer patients
Annals of Oncology, Vol. 17, Núm. 4, pp. 668-675
2005
-
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients
Annals of Oncology, Vol. 16, Núm. 7, pp. 1081-1086
2002
-
Low ERRC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer
Clinical Cancer Research, Vol. 8, Núm. 7, pp. 2286-2291